<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="editorial"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Molecules</journal-id><journal-id journal-id-type="iso-abbrev">Molecules</journal-id><journal-id journal-id-type="publisher-id">molecules</journal-id><journal-title-group><journal-title>Molecules</journal-title></journal-title-group><issn pub-type="epub">1420-3049</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7825126</article-id><article-id pub-id-type="pmid">33418945</article-id><article-id pub-id-type="doi">10.3390/molecules26020250</article-id><article-id pub-id-type="publisher-id">molecules-26-00250</article-id><article-categories><subj-group subj-group-type="heading"><subject>Editorial</subject></subj-group></article-categories><title-group><article-title>Editorial to Special Issue&#x02014;&#x0201c;Structure-Activity Relationships (SAR) of Natural Products&#x0201d;</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5985-9261</contrib-id><name><surname>Sippl</surname><given-names>Wolfgang</given-names></name><xref ref-type="aff" rid="af1-molecules-26-00250">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0795-394X</contrib-id><name><surname>Ntie-Kang</surname><given-names>Fidele</given-names></name><xref ref-type="aff" rid="af1-molecules-26-00250">1</xref><xref ref-type="aff" rid="af2-molecules-26-00250">2</xref><xref ref-type="aff" rid="af3-molecules-26-00250">3</xref><xref rid="c1-molecules-26-00250" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>McPhee</surname><given-names>Derek J.</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-molecules-26-00250"><label>1</label>Institute of Pharmacy, Martin-Luther University of Halle-Wittenberg, Kurt-Mothes-Str. 3, 06122 Halle, Germany; <email>wolfgang.sippl@pharmazie.uni-halle.de</email></aff><aff id="af2-molecules-26-00250"><label>2</label>Department of Chemistry, Faculty of Science, University of Buea, P.O. Box 63, Buea CM-00237, Cameroon</aff><aff id="af3-molecules-26-00250"><label>3</label>Institute of Botany, Technical University of Dresden, Zellescher Weg 20b, 01062 Dresden, Germany</aff><author-notes><corresp id="c1-molecules-26-00250"><label>*</label>Correspondence: <email>ntiekfidele@gmail.com</email> or <email>fidele.ntie-kang@tu-dresden.de</email>; Tel.: +237-673-872-475</corresp></author-notes><pub-date pub-type="epub"><day>06</day><month>1</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>1</month><year>2021</year></pub-date><volume>26</volume><issue>2</issue><elocation-id>250</elocation-id><history><date date-type="received"><day>28</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>30</day><month>12</month><year>2020</year></date></history><permissions><copyright-statement>&#x000a9; 2021 by the authors.</copyright-statement><copyright-year>2021</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions></article-meta></front><body><p>The topic of structure-activity-relationships (SAR) has recently drawn a lot of attention, and there is increasing interest in natural products (NPs) as a &#x0201c;source of inspiration&#x0201d; for the discovery of new lead compounds [<xref rid="B1-molecules-26-00250" ref-type="bibr">1</xref>,<xref rid="B2-molecules-26-00250" ref-type="bibr">2</xref>]. A quick search of the terms &#x0201c;natural product&#x0201d; and &#x0201c;structure-activity-relationships&#x0201d; in the PubMed database [<xref rid="B3-molecules-26-00250" ref-type="bibr">3</xref>], for example, yielded ~675,000 and 210,000 hits, respectively. A search of the term &#x0201c;secondary metabolite&#x0201d;, the less frequently employed term for NPs, in the same database yielded ~28,000 hits. First of all, compounds from natural sources have been fine-tuned over the ages to bind to specific classes of drug targets [<xref rid="B4-molecules-26-00250" ref-type="bibr">4</xref>,<xref rid="B5-molecules-26-00250" ref-type="bibr">5</xref>]. Thus, NPs are gaining attention as sources of lead compounds with novel scaffolds. Secondly, the relationship between chemical structure and the biological activities of compounds have often been investigated, with the view of finding out what chemical modification on the structure would improve the activity and/or reduce the toxic effects of compounds [<xref rid="B4-molecules-26-00250" ref-type="bibr">4</xref>,<xref rid="B5-molecules-26-00250" ref-type="bibr">5</xref>].</p><p>In this Special Issue (SI), we focus on NPs and NP mimics and their derivatives, which play a role in several biochemical processes, including those showing potential for development into drugs [<xref rid="B6-molecules-26-00250" ref-type="bibr">6</xref>]. The goal was to investigate compounds from biological sources (including fungal, microbial, marine, and plant sources), which host biosynthesis processes for making secondary metabolites. Although synthetically modified compounds (semi-synthetic NPs or pseudo-NPs) were also welcome in this SI, emphasis was on those derived from QSAR or SAR studies through computer modeling, in vitro and in vivo testing. The current SI is the result of a call that was sent out during mid-2019 and which resulted in several submissions, out of which nine papers (6 original research articles and 3 reviews) appeared in the final published version.</p><p>This SI is a follow up of a previously dedicated SI to this subject in the same journal [<xref rid="B7-molecules-26-00250" ref-type="bibr">7</xref>]. The topic SAR of NPs is quite broad in scope and could include areas like; bioactive NPs from diverse sources (including those of marine and terrestrial origins) with biological activities exploitable for the treatment of diverse diseases (including infectious diseases and cancer), e.g., mezzettiaside NPs and their disaccharide analogues are known to exhibit both anticancer (H460) and antibacterial (<italic>Bacillus subtilis</italic>) activities, and their SAR have been previously investigated [<xref rid="B8-molecules-26-00250" ref-type="bibr">8</xref>]. Topics that provide insight from binding free energy calculations, docking, pharmacophore modeling, and molecular dynamics involving small molecule NPs and NP mimics are also included [<xref rid="B9-molecules-26-00250" ref-type="bibr">9</xref>], along with quantitative structure-activity-relationships (QSAR) applications [<xref rid="B10-molecules-26-00250" ref-type="bibr">10</xref>], and may also extend to natural remedies and the pharmacogenomics of age-related and neurodegenerative disorders [<xref rid="B11-molecules-26-00250" ref-type="bibr">11</xref>], as well as their the implications in disease-associated epigenetic mechanisms and the chemoinformatic exploration of the chemical space and target space of natural products with epigenetic functions [<xref rid="B12-molecules-26-00250" ref-type="bibr">12</xref>]. In terms of applications beyond drug discovery, the role of NPs in environmental remediation could as well be considered [<xref rid="B13-molecules-26-00250" ref-type="bibr">13</xref>], as well as the epigenetic mechanisms that lead to the ecological balance between plants, fungi, and microbes, resulting in the biosynthesis of specific kinds of secondary metabolites [<xref rid="B14-molecules-26-00250" ref-type="bibr">14</xref>,<xref rid="B15-molecules-26-00250" ref-type="bibr">15</xref>]. More advanced topics could include polypharmacology and its association with treatment using natural remedies [<xref rid="B16-molecules-26-00250" ref-type="bibr">16</xref>], as well as protein glycosylation and implications for genes, environment, and plant and human diseases [<xref rid="B17-molecules-26-00250" ref-type="bibr">17</xref>,<xref rid="B18-molecules-26-00250" ref-type="bibr">18</xref>].</p><p>Case studies in the literature include SAR studies on NPs which have led to the synthesis of potent analogues, e.g., a recent review has presented diverse SAR studies which have led to the discovery of biologically useful analogues of macrocyclic NPs, illustrating the importance of designing building blocks accompanied by synthetic strategies [<xref rid="B19-molecules-26-00250" ref-type="bibr">19</xref>]. To illustrate this concept, Xiong et al. have investigated the signaling of synthetic analogues of the cyclic depsipeptide YM-254890, and the structurally similar FR900359, by investigating the SAR of the compounds and their synthetic analogues in G protein-coupled receptor (GPCR) signaling pathways [<xref rid="B20-molecules-26-00250" ref-type="bibr">20</xref>]. Other examples include SAR investigations of synthetic coumarin derivatives showing anti-tubercular activities [<xref rid="B21-molecules-26-00250" ref-type="bibr">21</xref>] and the use of SAR for the investigation of the anticancer activities of marine-derived bioactive compounds [<xref rid="B22-molecules-26-00250" ref-type="bibr">22</xref>].</p><p>The topics published in the current SI were quite diverse, touching the different areas highlighted in the previous paragraphs, e.g., molecular docking combined with pharmacophore-based virtual screening have led to the identification of the hydrolysable tannin NP, chebulagic acid, as a moderately active inhibitor of the influenza A virus ion channel [<xref rid="B23-molecules-26-00250" ref-type="bibr">23</xref>]. This study by Duncan et al. could further explain why the NP only showed experimental activity against the mutant, and not the wild type influenza virus. While J&#x000f6;hrer et al. were able to show that the position C-25 of a series of terpenooids from Black Cohosh (<italic>Actaearacemosa</italic>) could increase their cytotoxic effects, the arabinose moiety at position C-3 having an impact on this activity, Babiaka et al. used molecular docking of mono- and bis-indole alkaloids towards a homology model of <italic>Onchocerca ochengi</italic> thioredoxin reductase to attempt an explanation of the anti-filarial activities of these compounds [<xref rid="B24-molecules-26-00250" ref-type="bibr">24</xref>]. Kumar et al. combined several in vitro, in silico, and in vivo experiments to investigate the anti-anaphylactoid activity of Genistein in order to understand the possible molecular mechanisms of its action, which is mediated by a family of GPCRs [<xref rid="B25-molecules-26-00250" ref-type="bibr">25</xref>]. Meanwhile, Wurzlbauer et al. were able to show, through an investigation of over 60 analogues of the &#x003b2;-carboline alkaloid harmine, that &#x0201c;beneficial&#x0201d; residues at the C-1 position (occupied by methyl or chlorine) could make the difference between the desired kinase (DYRK1A) inhibition and the non-desired monoamine oxidase A inhibition by extensive docking of the two protein targets [<xref rid="B26-molecules-26-00250" ref-type="bibr">26</xref>]. Another study involved an attempt to reduce the cytotoxic activity of waste derived from <italic>Chenopodium quinoa</italic> husks by microwave-assisted hydrolysis reaction to produce monodesmosidic saponins from the husk extract in an optimal manner using mass spectrometry. Colson et al. were able to use the IMPALA in silico procedure to verify that the monodesmosidic saponins interacted preferably with a model phospholipid bilayer. This could provide an explanation why the measured hemolytic activity increased experimentally during the microwave hydrolytic process [<xref rid="B27-molecules-26-00250" ref-type="bibr">27</xref>].</p><p>Review articles in this SI discuss recent studies that attempt to investigate the SAR of NPs that have shown anti-HIV activities [<xref rid="B28-molecules-26-00250" ref-type="bibr">28</xref>], modulatory activities in zinc-independent histone deacetylases, sirtuins often implicated in human disease [<xref rid="B29-molecules-26-00250" ref-type="bibr">29</xref>] and SAR in plant-derived sweeteners [<xref rid="B30-molecules-26-00250" ref-type="bibr">30</xref>]. The readers are invited to enjoy the reading of the articles of this SI.</p></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, W.S. and F.N.-K.; writing&#x02014;original draft preparation, F.N.-K.; writing&#x02014;review and editing, W.S. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>This research received no external funding.</p></notes><notes><title>Institutional Review Board Statement</title><p>This study did not require institutional approval.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>No new data were created or analyzed in this study. Data sharing is not applicable to this article.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-molecules-26-00250"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name><name><surname>Cragg</surname><given-names>G.M.</given-names></name></person-group><article-title>Natural products as sources of new drugs from 1981 to 2014</article-title><source>J. Nat. Prod.</source><year>2016</year><volume>79</volume><fpage>629</fpage><lpage>661</lpage><pub-id pub-id-type="doi">10.1021/acs.jnatprod.5b01055</pub-id><?supplied-pmid 26852623?><pub-id pub-id-type="pmid">26852623</pub-id></element-citation></ref><ref id="B2-molecules-26-00250"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Newman</surname><given-names>D.J.</given-names></name></person-group><article-title>From natural products to drugs</article-title><source>Phys. Sci. Rev.</source><fpage>2018</fpage><pub-id pub-id-type="doi">10.1515/psr-2018-0111</pub-id></element-citation></ref><ref id="B3-molecules-26-00250"><label>3.</label><element-citation publication-type="gov"><article-title>PubMed Homepage</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://pubmed.ncbi.nlm.nih.gov/">https://pubmed.ncbi.nlm.nih.gov/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-12-24">(accessed on 24 December 2020)</date-in-citation></element-citation></ref><ref id="B4-molecules-26-00250"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Salvador-Reyes</surname><given-names>L.A.</given-names></name><name><surname>Luesch</surname><given-names>H.</given-names></name></person-group><article-title>Biological targets and mechanisms of action of natural products from marine cyanobacteria</article-title><source>Nat. Prod. Rep.</source><year>2015</year><volume>32</volume><fpage>478</fpage><lpage>503</lpage><?supplied-pmid 25571978?><pub-id pub-id-type="pmid">25571978</pub-id></element-citation></ref><ref id="B5-molecules-26-00250"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mabonga</surname><given-names>L.</given-names></name><name><surname>Kappo</surname><given-names>A.P.</given-names></name></person-group><article-title>Protein-protein interaction modulators: Advances, successes and remaining challenges</article-title><source>Biophys. Rev.</source><year>2019</year><volume>11</volume><fpage>559</fpage><lpage>581</lpage><pub-id pub-id-type="doi">10.1007/s12551-019-00570-x</pub-id><?supplied-pmid 31301019?><pub-id pub-id-type="pmid">31301019</pub-id></element-citation></ref><ref id="B6-molecules-26-00250"><label>6.</label><element-citation publication-type="web"><article-title>Special Issue &#x0201c;Structure&#x02013;Activity Relationships (SAR) of Natural Products&#x0201d;</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.mdpi.com/journal/molecules/special_issues/Molecules_Structure_Activity_Relationships">https://www.mdpi.com/journal/molecules/special_issues/Molecules_Structure_Activity_Relationships</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-12-24">(accessed on 24 December 2020)</date-in-citation></element-citation></ref><ref id="B7-molecules-26-00250"><label>7.</label><element-citation publication-type="web"><article-title>Special Issue &#x0201c;Structure-Activity Relationship of Natural Products 2018&#x0201d;</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.mdpi.com/journal/molecules/special_issues/structure_activity_2018">https://www.mdpi.com/journal/molecules/special_issues/structure_activity_2018</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-12-24">(accessed on 24 December 2020)</date-in-citation></element-citation></ref><ref id="B8-molecules-26-00250"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bajaj</surname><given-names>S.O.</given-names></name><name><surname>Shi</surname><given-names>P.</given-names></name><name><surname>Beuning</surname><given-names>P.J.</given-names></name><name><surname>O&#x02019;Doherty</surname><given-names>G.A.</given-names></name></person-group><article-title>Structure activity relationship study of mezzettiasides natural products and their four new disaccharide analogues for anticancer/antibacterial activity</article-title><source>Med. Chem. Commun.</source><year>2014</year><volume>5</volume><fpage>1138</fpage><lpage>1142</lpage></element-citation></ref><ref id="B9-molecules-26-00250"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peng</surname><given-names>J.</given-names></name><name><surname>Li</surname><given-names>Y.</given-names></name><name><surname>Zhou</surname><given-names>Y.</given-names></name><name><surname>Zhang</surname><given-names>L.</given-names></name><name><surname>Liu</surname><given-names>X.</given-names></name><name><surname>Zuo</surname><given-names>Z.</given-names></name></person-group><article-title>Pharmacophore modeling, molecular docking and molecular dynamics studies on natural products database to discover novel skeleton as non-purine xanthine oxidase inhibitors</article-title><source>J. Recept. Signal. Transduct. Res.</source><year>2018</year><volume>38</volume><fpage>246</fpage><lpage>255</lpage><pub-id pub-id-type="doi">10.1080/10799893.2018.1476544</pub-id><pub-id pub-id-type="pmid">29843539</pub-id></element-citation></ref><ref id="B10-molecules-26-00250"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malik</surname><given-names>N.</given-names></name><name><surname>Dhiman</surname><given-names>P.</given-names></name><name><surname>Khatkar</surname><given-names>A.</given-names></name></person-group><article-title>In silico and 3D QSAR studies of natural based derivatives as xanthine oxidase inhibitors</article-title><source>Curr. Top. Med. Chem.</source><year>2019</year><volume>19</volume><fpage>123</fpage><lpage>138</lpage><pub-id pub-id-type="pmid">30727896</pub-id></element-citation></ref><ref id="B11-molecules-26-00250"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Di Paolo</surname><given-names>M.</given-names></name><name><surname>Papi</surname><given-names>L.</given-names></name><name><surname>Gori</surname><given-names>F.</given-names></name><name><surname>Turillazzi</surname><given-names>E.</given-names></name></person-group><article-title>Natural products in neurodegenerative diseases: A great promise but an ethical challenge</article-title><source>Int. J. Mol. Sci.</source><year>2019</year><volume>20</volume><elocation-id>5170</elocation-id><pub-id pub-id-type="doi">10.3390/ijms20205170</pub-id></element-citation></ref><ref id="B12-molecules-26-00250"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sald&#x000ed;var-Gonz&#x000e1;lez</surname><given-names>F.I.</given-names></name><name><surname>G&#x000f3;mez-Garc&#x000ed;a</surname><given-names>A.</given-names></name><name><surname>Ch&#x000e1;vez-Ponce de Le&#x000f3;n</surname><given-names>D.E.</given-names></name><name><surname>S&#x000e1;nchez-Cruz</surname><given-names>N.</given-names></name><name><surname>Ruiz-Rios</surname><given-names>J.</given-names></name><name><surname>Pil&#x000f3;n-Jim&#x000e9;nez</surname><given-names>B.A.</given-names></name><name><surname>Medina-Franco</surname><given-names>J.L.</given-names></name></person-group><article-title>Inhibitors of DNA methyltransferases from natural sources: A computational perspective</article-title><source>Front. Pharmacol.</source><year>2018</year><volume>9</volume><fpage>1144</fpage><pub-id pub-id-type="pmid">30364171</pub-id></element-citation></ref><ref id="B13-molecules-26-00250"><label>13.</label><element-citation publication-type="gov"><person-group person-group-type="author"><collab>United States Environmental Protection Agency (EPA)</collab></person-group><article-title>Ecological Structure Activity Relationships (ECOSAR) Predictive Model</article-title><comment>Available online: <ext-link ext-link-type="uri" xlink:href="https://www.epa.gov/tsca-screening-tools/ecological-structure-activity-relationships-ecosar-predictive-model">https://www.epa.gov/tsca-screening-tools/ecological-structure-activity-relationships-ecosar-predictive-model</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2020-12-25">(accessed on 25 December 2020)</date-in-citation></element-citation></ref><ref id="B14-molecules-26-00250"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dubey</surname><given-names>A.</given-names></name><name><surname>Jeon</surname><given-names>J.</given-names></name></person-group><article-title>Epigenetic regulation of development and pathogenesis in fungal plant pathogens</article-title><source>Mol. Plant Pathol.</source><year>2017</year><volume>18</volume><fpage>887</fpage><lpage>898</lpage><pub-id pub-id-type="pmid">27749982</pub-id></element-citation></ref><ref id="B15-molecules-26-00250"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pfannenstiel</surname><given-names>B.T.</given-names></name><name><surname>Keller</surname><given-names>N.P.</given-names></name></person-group><article-title>On top of biosynthetic gene clusters: How epigenetic machinery influences secondary metabolism in fungi</article-title><source>Biotechnol. Adv.</source><year>2019</year><volume>37</volume><fpage>107345</fpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2019.02.001</pub-id><?supplied-pmid 30738111?><pub-id pub-id-type="pmid">30738111</pub-id></element-citation></ref><ref id="B16-molecules-26-00250"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ho</surname><given-names>T.T.</given-names></name><name><surname>Tran</surname><given-names>Q.T.N.</given-names></name><name><surname>Chai</surname><given-names>C.L.L.</given-names></name></person-group><article-title>The polypharmacology of natural products</article-title><source>Future Med. Chem.</source><year>2018</year><volume>10</volume><fpage>294</fpage><pub-id pub-id-type="doi">10.4155/fmc-2017-0294</pub-id><?supplied-pmid 29673257?><pub-id pub-id-type="pmid">29673257</pub-id></element-citation></ref><ref id="B17-molecules-26-00250"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spiro</surname><given-names>R.G.</given-names></name></person-group><article-title>Protein glycosylation: Nature, distribution, enzymatic formation, and disease implications of glycopeptide bonds</article-title><source>Glycobiology</source><year>2002</year><volume>12</volume><fpage>43R</fpage><lpage>56R</lpage><pub-id pub-id-type="doi">10.1093/glycob/12.4.43R</pub-id><?supplied-pmid 12042244?><pub-id pub-id-type="pmid">12042244</pub-id></element-citation></ref><ref id="B18-molecules-26-00250"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Verhelst</surname><given-names>X.</given-names></name><name><surname>Dias</surname><given-names>A.M.</given-names></name><name><surname>Colombel</surname><given-names>J.-F.</given-names></name><name><surname>Vermeire</surname><given-names>S.</given-names></name><name><surname>van Vlierberghe</surname><given-names>H.</given-names></name><name><surname>Callewaert</surname><given-names>N.</given-names></name><name><surname>Pinho</surname><given-names>S.S.</given-names></name></person-group><article-title>Protein glycosylation as a diagnostic and prognostic marker of chronic inflammatory gastrointestinal and liver diseases</article-title><source>Gastroenterology</source><year>2020</year><volume>158</volume><fpage>95</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1053/j.gastro.2019.08.060</pub-id><pub-id pub-id-type="pmid">31626754</pub-id></element-citation></ref><ref id="B19-molecules-26-00250"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Itoh</surname><given-names>H.</given-names></name><name><surname>Inoue</surname><given-names>M.</given-names></name></person-group><article-title>Comprehensive structure&#x02013;activity relationship studies of macrocyclic natural products enabled by their total syntheses</article-title><source>Chem. Rev.</source><year>2019</year><volume>119</volume><fpage>10002</fpage><lpage>10031</lpage><pub-id pub-id-type="doi">10.1021/acs.chemrev.9b00063</pub-id><pub-id pub-id-type="pmid">30945851</pub-id></element-citation></ref><ref id="B20-molecules-26-00250"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>X.-F.</given-names></name><name><surname>Zhang</surname><given-names>H.</given-names></name><name><surname>Boesgaard</surname><given-names>M.W.</given-names></name><name><surname>Underwood</surname><given-names>C.R.</given-names></name><name><surname>Br&#x000e4;uner-Osborne</surname><given-names>H.</given-names></name><name><surname>Str&#x000f8;mgaard</surname><given-names>K.</given-names></name></person-group><article-title>Structure&#x02013;activity relationship studies of the natural product G<sub>q/11</sub> protein inhibitor YM-254890</article-title><source>ChemMedChem</source><year>2019</year><volume>14</volume><fpage>865</fpage><lpage>870</lpage><pub-id pub-id-type="doi">10.1002/cmdc.201900018</pub-id><pub-id pub-id-type="pmid">30790465</pub-id></element-citation></ref><ref id="B21-molecules-26-00250"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pires</surname><given-names>C.T.</given-names></name><name><surname>Scodro</surname><given-names>R.B.</given-names></name><name><surname>Cortez</surname><given-names>D.A.</given-names></name><name><surname>Brenzan</surname><given-names>M.A.</given-names></name><name><surname>Siqueira</surname><given-names>V.L.</given-names></name><name><surname>Caleffi-Ferracioli</surname><given-names>K.R.</given-names></name><name><surname>Vieira</surname><given-names>L.C.</given-names></name><name><surname>Monteiro</surname><given-names>J.L.</given-names></name><name><surname>Corr&#x000ea;a</surname><given-names>A.G.</given-names></name><name><surname>Cardoso</surname><given-names>R.F.</given-names></name></person-group><article-title>Structure-activity relationship of natural and synthetic coumarin derivatives against <italic>Mycobacterium tuberculosis</italic></article-title><source>Future Med. Chem.</source><year>2020</year><volume>12</volume><fpage>1533</fpage><lpage>1546</lpage><pub-id pub-id-type="doi">10.4155/fmc-2018-0281</pub-id><pub-id pub-id-type="pmid">32820960</pub-id></element-citation></ref><ref id="B22-molecules-26-00250"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fedorov</surname><given-names>S.N.</given-names></name><name><surname>Stonik</surname><given-names>V.A.</given-names></name><name><surname>Honecker</surname><given-names>F.</given-names></name><name><surname>Sergey</surname><given-names>A.</given-names></name><name><surname>Dyshlovoy</surname><given-names>S.A.</given-names></name></person-group><article-title>Structure-activity relationship studies of new marine anticancer agents and their synthetic analogues</article-title><source>Curr. Med. Chem.</source><year>2017</year><volume>24</volume><fpage>4779</fpage><lpage>4799</lpage><pub-id pub-id-type="doi">10.2174/0929867324666161121115404</pub-id><pub-id pub-id-type="pmid">27903218</pub-id></element-citation></ref><ref id="B23-molecules-26-00250"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duncan</surname><given-names>M.C.</given-names></name><name><surname>Ongu&#x000e9;n&#x000e9;</surname><given-names>P.A.</given-names></name><name><surname>Kihara</surname><given-names>I.</given-names></name><name><surname>Nebangwa</surname><given-names>D.N.</given-names></name><name><surname>Naidu</surname><given-names>M.E.</given-names></name><name><surname>Williams</surname><given-names>D.E.</given-names></name><name><surname>Balgi</surname><given-names>A.D.</given-names></name><name><surname>Andrae-Marobela</surname><given-names>K.</given-names></name><name><surname>Roberge</surname><given-names>M.</given-names></name><name><surname>Andersen</surname><given-names>R.J.</given-names></name><etal/></person-group><article-title>Virtual Screening Identifies Chebulagic Acid as an Inhibitor of the M2(S31N) Viral Ion Channel and Influenza A Virus</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>2903</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25122903</pub-id></element-citation></ref><ref id="B24-molecules-26-00250"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babiaka</surname><given-names>S.B.</given-names></name><name><surname>Simoben</surname><given-names>C.V.</given-names></name><name><surname>Abuga</surname><given-names>K.O.</given-names></name><name><surname>Mbah</surname><given-names>J.A.</given-names></name><name><surname>Karpoormath</surname><given-names>R.</given-names></name><name><surname>Ongarora</surname><given-names>D.</given-names></name><name><surname>Mugo</surname><given-names>H.</given-names></name><name><surname>Monya</surname><given-names>E.</given-names></name><name><surname>Cho-Ngwa</surname><given-names>F.</given-names></name><name><surname>Sippl</surname><given-names>W.</given-names></name><etal/></person-group><article-title>Alkaloids with Anti-Onchocercal Activity from Voacanga africana Stapf (Apocynaceae): Identification and Molecular Modeling</article-title><source>Molecules</source><year>2021</year><volume>26</volume><fpage>70</fpage></element-citation></ref><ref id="B25-molecules-26-00250"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kumar</surname><given-names>M.</given-names></name><name><surname>Singh</surname><given-names>K.</given-names></name><name><surname>Duraisamy</surname><given-names>K.</given-names></name><name><surname>Allam</surname><given-names>A.A.</given-names></name><name><surname>Ajarem</surname><given-names>J.</given-names></name><name><surname>Chow</surname><given-names>B.K.C.</given-names></name></person-group><article-title>Protective Effect of Genistein against Compound 48/80 Induced Anaphylactoid Shock via Inhibiting MAS Related G Protein-Coupled Receptor X2 (MRGPRX2)</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>1028</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25051028</pub-id><?supplied-pmid 32106575?><pub-id pub-id-type="pmid">32106575</pub-id></element-citation></ref><ref id="B26-molecules-26-00250"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wurzlbauer</surname><given-names>A.</given-names></name><name><surname>R&#x000fc;ben</surname><given-names>K.</given-names></name><name><surname>G&#x000fc;rdal</surname><given-names>E.</given-names></name><name><surname>Chaikuad</surname><given-names>A.</given-names></name><name><surname>Knapp</surname><given-names>S.</given-names></name><name><surname>Sippl</surname><given-names>W.</given-names></name><name><surname>Becker</surname><given-names>W.</given-names></name><name><surname>Bracher</surname><given-names>F.</given-names></name></person-group><article-title>How to Separate Kinase Inhibition from Undesired Monoamine Oxidase A Inhibition&#x02014;The Development of the DYRK1A Inhibitor AnnH75 from the Alkaloid Harmine</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>5962</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25245962</pub-id><?supplied-pmid 33339338?><pub-id pub-id-type="pmid">33339338</pub-id></element-citation></ref><ref id="B27-molecules-26-00250"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Colson</surname><given-names>E.</given-names></name><name><surname>Savarino</surname><given-names>P.</given-names></name><name><surname>Claereboudt</surname><given-names>E.J.</given-names></name><name><surname>Cabrera-Barjas</surname><given-names>G.</given-names></name><name><surname>Deleu</surname><given-names>M.</given-names></name><name><surname>Lins</surname><given-names>L.</given-names></name><name><surname>Eeckhaut</surname><given-names>I.</given-names></name><name><surname>Flammang</surname><given-names>P.</given-names></name><name><surname>Gerbaux</surname><given-names>P.</given-names></name></person-group><article-title>Enhancing the Membranolytic Activity of Chenopodium quinoa Saponins by Fast Microwave Hydrolysis</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>1731</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25071731</pub-id><?supplied-pmid 32283763?><pub-id pub-id-type="pmid">32283763</pub-id></element-citation></ref><ref id="B28-molecules-26-00250"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>R.</given-names></name><name><surname>Sharma</surname><given-names>P.</given-names></name><name><surname>Gupta</surname><given-names>G.K.</given-names></name><name><surname>Ntie-Kang</surname><given-names>F.</given-names></name><name><surname>Kumar</surname><given-names>D.</given-names></name></person-group><article-title>Structure-Activity-Relationship and Mechanistic Insights for Anti-HIV Natural Products</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>2070</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25092070</pub-id></element-citation></ref><ref id="B29-molecules-26-00250"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mayack</surname><given-names>B.K.</given-names></name><name><surname>Sippl</surname><given-names>W.</given-names></name><name><surname>Ntie-Kang</surname><given-names>F.</given-names></name></person-group><article-title>Natural Products as Modulators of Sirtuins</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>3287</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25143287</pub-id></element-citation></ref><ref id="B30-molecules-26-00250"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>&#x004aa;i&#x000e7;ek</surname><given-names>S.S.</given-names></name></person-group><article-title>Structure-Dependent Activity of Plant-Derived Sweeteners</article-title><source>Molecules</source><year>2020</year><volume>25</volume><elocation-id>1946</elocation-id><pub-id pub-id-type="doi">10.3390/molecules25081946</pub-id></element-citation></ref></ref-list></back></article>